- Home
- SCPH vs DMF Comparison
SCPH vs DMF Comparison
Compare SCPH & DMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- DMF
- Stock Information
- Founded
- SCPH 2013
- DMF 1988
- Country
- SCPH United States
- DMF United States
- Employees
- SCPH N/A
- DMF N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- DMF Finance/Investors Services
- Sector
- SCPH Health Care
- DMF Finance
- Exchange
- SCPH Nasdaq
- DMF Nasdaq
- Market Cap
- SCPH 173.6M
- DMF 143.6M
- IPO Year
- SCPH 2017
- DMF N/A
- Fundamental
- Price
- SCPH $3.84
- DMF $6.93
- Analyst Decision
- SCPH Strong Buy
- DMF
- Analyst Count
- SCPH 3
- DMF 0
- Target Price
- SCPH $14.00
- DMF N/A
- AVG Volume (30 Days)
- SCPH 289.6K
- DMF 60.7K
- Earning Date
- SCPH 08-13-2025
- DMF 01-01-0001
- Dividend Yield
- SCPH N/A
- DMF 2.66%
- EPS Growth
- SCPH N/A
- DMF N/A
- EPS
- SCPH N/A
- DMF 0.15
- Revenue
- SCPH $41,982,000.00
- DMF N/A
- Revenue This Year
- SCPH $108.95
- DMF N/A
- Revenue Next Year
- SCPH $73.83
- DMF N/A
- P/E Ratio
- SCPH N/A
- DMF $45.13
- Revenue Growth
- SCPH 138.10
- DMF N/A
- 52 Week Low
- SCPH $1.94
- DMF $5.37
- 52 Week High
- SCPH $5.65
- DMF $6.79
- Technical
- Relative Strength Index (RSI)
- SCPH 56.83
- DMF 45.82
- Support Level
- SCPH $3.86
- DMF $6.86
- Resistance Level
- SCPH $4.17
- DMF $6.97
- Average True Range (ATR)
- SCPH 0.23
- DMF 0.05
- MACD
- SCPH -0.06
- DMF 0.00
- Stochastic Oscillator
- SCPH 33.33
- DMF 61.04
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About DMF BNY Mellon Municipal Income Inc.
BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.